1. | giovannriveracot | |
2. | 2thwardz | |
3. | matthewsmelt6 | |
4. | carter0 | |
5. | shiryteach |
1. | giovannriveracot | |
2. | 2thwardz | |
3. | matthewsmelt6 | |
4. | carter0 | |
5. | shiryteach |
1. | shawngill0789 03/05/2018 YOU SAY!? - Jefferies raises price target to $46 from $30 |
2. | 2thwardz 01/26/2018 So good |
3. | matthewsmelt6 05/08/2018 Atara Biotherapeutics Expands T-Cell Immunotherapy Collaboration to Advance Next-Generation CAR T Technologies in Oncology, Autoimmune and Other Diseases |
4. | giovannriveracot 01/04/2018 Secondary killing the stock today |
5. | carter0 03/05/2018 Nice! |
6. | giovannriveracot 01/26/2018 Wowza! 2018 has been hot! |
7. | 2thwardz 02/27/2018 Atara Biotherapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Recent Operational Progress |
8. | giovannriveracot 03/05/2018 Nice buy {Image} |
9. | carter0 06/15/2018 Atara Biotherapeutics' Tab-cel™ Achieves Positive Long-Term Outcomes in Phase 2 Studies of Patients with Epstein-Barr Virus Associated Post-Transplant Lymphomas |
10. | giovannriveracot 01/26/2018 Cowen & Company initiates as an outperform |